Systematic Aetiological Assessment of Myocarditis : A Prospective Cohort Study
BACKGROUND: Myocarditis is commonly diagnosed in the intensive care cardiology unit (ICCU). No current recommendation nor guideline aids exist for aetiological assessments.
METHODS: From September 2021 to October 2023, 84 patients with acute myocarditis underwent thorough and systematic serum and blood cell panel evaluations to determine the most common causes of myocarditis.
RESULTS: Of the 84 patients (median age 34 years, range 22-41 years, 79% male), 16 presented with complicated myocarditis. The systematic aetiological assessment revealed that 36% of patients were positive for lupus anticoagulant, 12% for antinuclear antibodies, 8% for anti-heart antibodies, and 12% for anti-striated muscle antibodies. Viral serology did not yield any significant results. After the aetiological assessment, one patient was diagnosed with an autoimmune inflammatory disorder (Still's disease). T-cell subset analyses indicated that myocarditis severity tended to increase with the T-cell lymphopenia status.
CONCLUSIONS: A comprehensive, systematic aetiological assessment was of limited value in terms of predicting the clinical or therapeutic outcomes in myocarditis patients presenting to the ICCU.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Journal of clinical medicine - 13(2024), 4 vom: 10. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Michel, Vincent [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aetiological assessment |
---|
Anmerkungen: |
Date Revised 27.02.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm13041025 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368883183 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368883183 | ||
003 | DE-627 | ||
005 | 20240229164705.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm13041025 |2 doi | |
028 | 5 | 2 | |a pubmed24n1309.xml |
035 | |a (DE-627)NLM368883183 | ||
035 | |a (NLM)38398340 | ||
035 | |a (PII)1025 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Michel, Vincent |e verfasserin |4 aut | |
245 | 1 | 0 | |a Systematic Aetiological Assessment of Myocarditis |b A Prospective Cohort Study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a BACKGROUND: Myocarditis is commonly diagnosed in the intensive care cardiology unit (ICCU). No current recommendation nor guideline aids exist for aetiological assessments | ||
520 | |a METHODS: From September 2021 to October 2023, 84 patients with acute myocarditis underwent thorough and systematic serum and blood cell panel evaluations to determine the most common causes of myocarditis | ||
520 | |a RESULTS: Of the 84 patients (median age 34 years, range 22-41 years, 79% male), 16 presented with complicated myocarditis. The systematic aetiological assessment revealed that 36% of patients were positive for lupus anticoagulant, 12% for antinuclear antibodies, 8% for anti-heart antibodies, and 12% for anti-striated muscle antibodies. Viral serology did not yield any significant results. After the aetiological assessment, one patient was diagnosed with an autoimmune inflammatory disorder (Still's disease). T-cell subset analyses indicated that myocarditis severity tended to increase with the T-cell lymphopenia status | ||
520 | |a CONCLUSIONS: A comprehensive, systematic aetiological assessment was of limited value in terms of predicting the clinical or therapeutic outcomes in myocarditis patients presenting to the ICCU | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a aetiological assessment | |
650 | 4 | |a autoimmune and inflammatory disorders | |
650 | 4 | |a myocarditis | |
700 | 1 | |a Lazaro, Estibaliz |e verfasserin |4 aut | |
700 | 1 | |a Fauthoux, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Cetran, Laura |e verfasserin |4 aut | |
700 | 1 | |a Contin-Bordes, Cécile |e verfasserin |4 aut | |
700 | 1 | |a Blanco, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Seguy, Benjamin |e verfasserin |4 aut | |
700 | 1 | |a Baudinet, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Coste, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Gerbaud, Edouard |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 13(2024), 4 vom: 10. Feb. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2024 |g number:4 |g day:10 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm13041025 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2024 |e 4 |b 10 |c 02 |